ArticleJournal of thoracic disease2025

The COURSE trial and beyond: rethinking chronic obstructive pulmonary disease exacerbation management with biologics.

Fumihiro Kashizaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.